| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |